Tag: Maternal-Fetal Medicine Excellence Award

Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Published on by World Science Awards

Dr. Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Associate Professor at Quaid-i-Azam University, Pakistan

Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education.

Profile

Education

Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences.

Professional Experience

Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field.

Research Interest

Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems.

Research Skills

Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies.

Award and Recognition

Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care.

Conclusion

Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition.

Publication Top Notes

  • “Non-pharmacological management of hypertension: in the light of current research”
    • Journal: Irish Journal of Medical Science (1971-)
    • Cited by: 180
    • Year: 2019
    • Volume: 188
    • Pages: 437-452
  • “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)”
    • Journal: Expert Opinion on Drug Delivery
    • Cited by: 148
    • Year: 2017
    • Volume: 14, Issue 11
    • Pages: 1325-1340
  • “Proniosomes derived niosomes: recent advancements in drug delivery and targeting”
    • Journal: Drug Delivery
    • Cited by: 121
    • Year: 2017
    • Volume: 24, Issue 2
    • Pages: 56-69
  • “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers”
    • Journal: Carbohydrate Polymers
    • Cited by: 106
    • Year: 2020
    • Volume: 250
    • Pages: 116800
  • “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)”
    • Journal: Journal of Medicinal Plants Research
    • Cited by: 93
    • Year: 2010
    • Volume: 4, Issue 19
    • Pages: 1987-1990
  • “Polymeric nanogels as versatile nanoplatforms for biomedical applications”
    • Journal: Journal of Nanomaterials
    • Cited by: 81
    • Year: 2019
    • Volume: 2019, Issue 1
    • Pages: 1526186
  • “Hemostatic strategies for uncontrolled bleeding: A comprehensive update”
    • Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
    • Cited by: 73
    • Year: 2021
    • Volume: 109
  • “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product”
    • Journal: Journal of Drug Delivery Science and Technology
    • Cited by: 72
    • Year: 2019
    • Volume: 51
    • Pages: 583-590
  • “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis”
    • Journal: International Journal of Clinical Pharmacy
    • Cited by: 56
    • Year: 2021
    • Volume: 43
    • Pages: 486-501
  • “Co-delivery strategies to overcome multidrug resistance in ovarian cancer”
    • Journal: International Journal of Pharmaceutics
    • Cited by: 47
    • Year: 2017
    • Volume: 533, Issue 1
    • Pages: 111-124
  • “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation”
    • Journal: The Scientific World Journal
    • Cited by: 46
    • Year: 2012
    • Volume: 2012, Issue 1
    • Pages: 842348

 

 

Amihai Rottenstreich | Maternal Fetal Medicine | Best Researcher Award

Published on by World Science Awards

Prof. Amihai Rottenstreich | Maternal Fetal Medicine | Best Researcher Award

Maternal Fetal Medicine Specialist of Rockefeller University, United States.

Dr. Amihai Rottenstreich is a distinguished researcher and clinician with a robust academic and professional background. He earned his B.Sc. and M.D. degrees summa cum laude from Technion – Israel Institute of Technology. His research experience spans prestigious institutions, including St Thomas’ Hospital and Rockefeller University, focusing on obstetric hematology and thrombosis. Dr. Rottenstreich has received multiple awards, such as the Betty Shane Scholarship Award and the Kochman Best Researcher Award, recognizing his impactful research. He has secured several research grants for innovative projects, like antiplatelet drugs and postpartum thromboprophylaxis. His active roles in professional societies and editorial boards, combined with his mentorship of PhD and Master’s students, highlight his commitment to advancing his field. Dr. Rottenstreich’s impressive achievements and contributions make him a strong candidate for the Research for Innovation Excellence Award.

Profile

Education

Amihai Rottenstreich, MD, has a distinguished educational background with a focus on medical sciences and clinical research. He earned his B.Sc. in Medical Sciences summa cum laude from Technion – Israel Institute of Technology in 2010, achieving a notable GPA of 95.5. He continued his studies at Technion, obtaining his Medical Doctor degree summa cum laude in 2013, with a GPA of 94.5. His thesis investigated the relationship between viral load of varicella zoster virus and the clinical progression of central nervous system infections. Following his medical education, Dr. Rottenstreich completed a rotating internship at Hadassah-Hebrew University Medical Center, Jerusalem, in 2014. He then pursued specialized training, including research fellowships at St Thomas’ Hospital in London and Rockefeller University in New York. His ongoing fellowship at the Clinical Scholars Program and Blood and Vascular Biology Laboratory further underscores his commitment to advancing medical research.

Professional Experience

Dr. Amihai Rottenstreich has a distinguished professional trajectory marked by extensive research and clinical experience. After completing his rotating internship at Hadassah-Hebrew University Medical Center, he specialized in hematology as a research fellow in the Coagulation Unit from 2016 to 2017. His residency in Obstetrics and Gynecology at the same institution spanned from 2017 to 2022. He further honed his expertise with a research fellowship in obstetric hematology at St Thomas’ Hospital in London in 2019, working under Prof. Beverly Hunt. Currently, Dr. Rottenstreich is engaged in a fellowship program at Rockefeller University and the Center for Maternal Fetal Medicine in New York, focusing on advanced research in maternal and fetal health. His roles have consistently integrated high-impact research with clinical practice, demonstrating his commitment to advancing medical science and improving patient care.

Research Interest

Dr. Amihai Rottenstreich’s research interests are primarily focused on obstetric hematology, thrombosis, and thrombophilia. His work explores the complex interactions between coagulation systems and pregnancy-related complications, such as antiphospholipid syndrome and preeclampsia. He investigates the molecular mechanisms underlying these conditions and their impact on maternal and fetal health. His research aims to improve diagnostic and therapeutic approaches for managing thrombotic disorders in pregnancy, including the use of antiplatelet drugs and thromboprophylaxis strategies. Additionally, Dr. Rottenstreich’s projects encompass the study of glycemic balance and its effects on pregnancy outcomes, as well as innovative models for evaluating treatment efficacy in tumor development. His work integrates clinical and laboratory research to advance understanding and improve patient care in obstetric and gynecological settings.

Research Skills

Amihai Rottenstreich, MD, exhibits exceptional research skills across a broad spectrum of medical and clinical fields. His expertise spans obstetric hematology, thrombosis, and reproductive health, as evidenced by his impactful research on varicella zoster virus and anticoagulant therapies. Dr. Rottenstreich’s proficiency in designing and conducting complex studies is highlighted by his successful research fellowships at prestigious institutions like St Thomas’ Hospital and Rockefeller University. He has secured multiple research grants, including significant funding for innovative projects on antiplatelet drugs and low-dose aspirin in preeclampsia prevention. His contributions to the academic community are further demonstrated through his roles as an ad hoc reviewer and editorial board member for numerous high-impact journals. Dr. Rottenstreich’s ability to mentor students and lead research projects underscores his strong analytical skills, methodological rigor, and commitment to advancing medical science through both clinical and laboratory research.

Award and Recognition

Amihai Rottenstreich, MD, has garnered numerous prestigious awards and recognitions throughout his career, underscoring his excellence in medical research and clinical practice. He achieved summa cum laude honors for both his B.Sc. and M.D. degrees from Technion – Israel Institute of Technology and has been consistently recognized for his academic excellence. Notable accolades include the Betty Shane Scholarship Award for research excellence, the Kochman Best Researcher Award from Hebrew University, and the Gendal Young Researcher Award. His research contributions have been further acknowledged with multiple best paper awards, including those from the Israeli Maternal & Fetal Medicine Annual Congress and the International Federation for the Surgery of Obesity and Metabolic Disorders European Chapter. Dr. Rottenstreich’s innovative work has also been supported by several significant research grants, including those from the Clinical Scholars Program at Rockefeller University and the Mirski Foundation.

Conclusion

Amihai Rottenstreich, MD, is a highly qualified candidate for the Research for Innovation Excellence Award. His strong academic background, significant research contributions, and active engagement in the academic community make him a standout nominee. Addressing areas for improvement, such as detailing the broader impact of his research and innovative projects, could further solidify his candidacy. His proven track record of excellence in research, awards, and grants demonstrates his potential for continued innovation and impact in his field.

Publication Top Notes

  1. Placenta-Mediated Conditions: Past, Present, and Future Perspectives
  2. Controversies and Clarifications Regarding the Role of Aspirin in Preeclampsia Prevention: A Focused Review